Gene · 1633
Papers2,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. | Diagnostics (Basel) | 2022 | 35204377 | PubTator, text mining | PubMed |
| Re-Discovery of Pyrimidine Salvage as Target in Cancer Therapy. | Cells | 2022 | 35203388 | PubTator, text mining | PubMed |
| Cell surface nucleolin is a novel ADAMTS5 receptor mediating endothelial cell apoptosis. | Cell Death Dis | 2022 | 35197459 | PubTator, text mining | PubMed |
| Editorial: Molecular Biomarkers for Gastric Cancer. | Front Oncol | 2022 | 35186772 | PubTator, text mining | PubMed |
| Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review. | Lancet Glob Health | 2022 | 35180408 | PubTator, text mining | PubMed |
| Pioneer Role of Extracellular Vesicles as Modulators of Cancer Initiation in Progression, Drug Therapy, and Vaccine Prospects. | Cells | 2022 | 35159299 | PubTator, text mining | PubMed |
| Epigenetic Therapies and Biomarkers in Breast Cancer. | Cancers (Basel) | 2022 | 35158742 | PubTator, text mining | PubMed |
| microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1. | Mol Oncol | 2022 | 35148461 | PubTator, text mining | PubMed |
| Gemcitabine-Induced Hemolytic Uremic Syndrome in Lung Cancer: A Case Report. | Cureus | 2022 | 35145816 | PubTator, text mining | PubMed |
| Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13. | Biotechniques | 2022 | 35119307 | PubTator, text mining | PubMed |
| Advances in Thymidine Kinase 2 Deficiency: Clinical Aspects, Translational Progress, and Emerging Therapies. | J Neuromuscul Dis | 2022 | 35094997 | PubTator, text mining | PubMed |
| Abstracts of the Fourth Brainstorming Research Assembly for Young Neuroscientists (BraYn), Italy, 20-22 October 2021. | Neurol Int | 2022 | 35076571 | PubTator, text mining | PubMed |
| Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating Agents. | Cancer Control | 2022 | 35067084 | PubTator, text mining | PubMed |
| Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review. | Cancers (Basel) | 2022 | 35053614 | PubTator, text mining | PubMed |
| Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells. | Cell Rep | 2022 | 35021095 | PubTator, text mining | PubMed |
| Two Possible Strategies for Drug Modification of Gemcitabine and Future Contributions to Personalized Medicine. | Molecules | 2022 | 35011522 | PubTator, text mining | PubMed |
| Arterial Administration of DNA Crosslinking Agents with Restraint of Homologous Recombination Repair by Intravenous Low-Dose Gemcitabine Is Effective for Locally Advanced Pancreatic Cancer. | Cancers (Basel) | 2022 | 35008384 | PubTator, text mining | PubMed |
| The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy. | Cancers (Basel) | 2022 | 35008381 | PubTator, text mining | PubMed |
| Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response. | Pharmacol Ther | 2022 | 34999182 | PubTator, text mining | PubMed |
| Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer. | World J Surg Oncol | 2022 | 34980144 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1633/papers?page=20